These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35156200)

  • 21. It's time to measure disability in spinal muscular atrophy.
    Trabacca A; Ferrante C; De Rinaldis M
    Acta Myol; 2022 Jun; 41(2):57-58. PubMed ID: 35832503
    [No Abstract]   [Full Text] [Related]  

  • 22. [Werdnig-Hoffmann amyotrophy in a 7-month-old child].
    Kutafin IuF; Osipov SM
    Pediatriia; 1990; (4):91-3. PubMed ID: 2371136
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.
    Kirschner J; Butoianu N; Goemans N; Haberlova J; Kostera-Pruszczyk A; Mercuri E; van der Pol WL; Quijano-Roy S; Sejersen T; Tizzano EF; Ziegler A; Servais L; Muntoni F
    Eur J Paediatr Neurol; 2021 Jan; 30():103-104. PubMed ID: 33640649
    [No Abstract]   [Full Text] [Related]  

  • 24. Lumbosacral ventral spinal nerve root atrophy identified on MRI in a case of spinal muscular atrophy type II.
    Smith G; Bell SK; Sladky JT; Kang PB; Albayram MS
    Clin Imaging; 2019; 53():134-137. PubMed ID: 30340076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal detectable change and minimal clinically important difference in spinal muscular atrophy patients.
    Vázquez-Costa JF; Hervás D
    Eur J Neurol; 2021 Jun; 28(6):e40-e41. PubMed ID: 33604967
    [No Abstract]   [Full Text] [Related]  

  • 26. Ontario Newborn Screening for Spinal Muscular Atrophy: The First Year.
    Kernohan KD; McMillan HJ; Yeh E; Lacaria M; Kowalski M; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; Mackenzie A; Chakraborty P
    Can J Neurol Sci; 2022 Nov; 49(6):821-823. PubMed ID: 34620260
    [No Abstract]   [Full Text] [Related]  

  • 27. Managing pregnancy in a spinal muscular atrophy type III patient in Indonesia: a case report.
    Setyaningrum CTS; Harahap ISK; Nurputra DK; Rachman IT; Harahap NIF
    J Med Case Rep; 2022 Jan; 16(1):14. PubMed ID: 35033190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
    Wood MF; Hughes SC; Hache LP; Naylor EW; Abdel-Hamid HZ; Barmada MM; Dobrowolski SF; Stickler DE; Clemens PR
    Muscle Nerve; 2014 Jun; 49(6):822-8. PubMed ID: 24307279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.
    Lin PJ; Yeh WS; Neumann PJ
    Pediatr Neurol; 2017 Jan; 66():69-75. PubMed ID: 27769729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infantile spinal muscular atrophy : therapeutic (R)evolution].
    Daron A; Delstanche S; Dangouloff T; Servais L
    Rev Med Liege; 2019 Feb; 74(2):82-85. PubMed ID: 30793560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and mutational characteristics of spinal muscular atrophy with respiratory distress type 1 in The Netherlands.
    Stalpers XL; Verrips A; Poll-The BT; Cobben JM; Snoeck IN; de Coo IF; Brooks A; Bulk S; Gooskens R; Fock A; Verschuuren-Bemelmans C; Sinke RJ; de Visser M; Lemmink HH
    Neuromuscul Disord; 2013 Jun; 23(6):461-8. PubMed ID: 23566544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal newborn screening for spinal muscular atrophy in Ukraine.
    Olkhovych N; Gorovenko N; Servais L
    Lancet; 2023 Jul; 402(10398):288-289. PubMed ID: 37481267
    [No Abstract]   [Full Text] [Related]  

  • 34. Maximising returns: combining newborn screening with gene therapy for spinal muscular atrophy.
    Gillingwater TH
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1252. PubMed ID: 34321342
    [No Abstract]   [Full Text] [Related]  

  • 35. Interventions for spinal muscular atrophy: an impetus for newborn screening.
    EBioMedicine; 2021 Jul; 69():103507. PubMed ID: 34315607
    [No Abstract]   [Full Text] [Related]  

  • 36. Newborn screening for SMA in Southern Belgium.
    Boemer F; Caberg JH; Dideberg V; Dardenne D; Bours V; Hiligsmann M; Dangouloff T; Servais L
    Neuromuscul Disord; 2019 May; 29(5):343-349. PubMed ID: 31030938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2.
    Glascock J; Sampson J; Connolly AM; Darras BT; Day JW; Finkel R; Howell RR; Klinger KW; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2020; 7(2):97-100. PubMed ID: 32007960
    [No Abstract]   [Full Text] [Related]  

  • 38. Universal Newborn Screening for Spinal Muscular Atrophy.
    Oskoui M; Dangouloff T; Servais L
    JAMA Pediatr; 2024 Jun; 178(6):520-521. PubMed ID: 38587838
    [No Abstract]   [Full Text] [Related]  

  • 39. A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland.
    Gillingwater TH; McWilliam C; Horrocks I; McWilliam K; Hamilton M; Fletcher E; Williams N; Smith S; Parson SH
    Scott Med J; 2022 Feb; 67(1):46-47. PubMed ID: 35147460
    [No Abstract]   [Full Text] [Related]  

  • 40. [Expert consensus on newborn screening for spinal muscular atrophy (2023 edition)].
    ;
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(27):2075-2081. PubMed ID: 37455125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.